| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/02/2007 | US7157546 Water-soluble polymer alkanals |
| 01/02/2007 | US7157500 Nitrosylation of protein SH groups and amino acid residues as a therapeutic modality |
| 01/02/2007 | US7157439 a cellulose and a HoxB3 homeotic nucleic acid or protein; improved neovascularization |
| 01/02/2007 | US7157438 Rhob as a suppressor of cancer cell growth and cell transformation |
| 01/02/2007 | US7157435 Delivering a dosage of a growth factor-encoding transgene composition to preselected delivery sites in the brain where the encoded growth factor is expressed and stimulates axonal growth; mimimally invasive; Alzheimer's, Parkinson diseases |
| 01/02/2007 | US7157428 Introducing into a site of the meniscus injury, lesion or tear an adhesive rapidly gelling biodegradable derivatized collagen-PEG hydrogel complex wherein said derivatized collagen is alkylated Type I collagen |
| 01/02/2007 | US7157427 Inhibitiing bacterial infection in a mammal wherein infection is caused by Bacillus or Escheria bacterium by administering a protein |
| 01/02/2007 | US7157426 such as peptide YY, Neuropeptide Y, or Pancreatic polypeptide with solubilizing agent (cyclodextran), chelating agent (ethylenediamine tetraacetic acid), and polyol such as sucrose |
| 01/02/2007 | US7157425 Apolipoprotein agonist for use in the treatment of dyslipidemia |
| 01/02/2007 | US7157423 Using fumaric acid mono- and diamides, or monoamido fumaric acid monoesters for therapy of an autoimmune disease; transplantation medicine; therapy of mitochondrial diseases, for therapy of NF-kappaB mediated diseases |
| 01/02/2007 | US7157422 Glycogen synthase kinase-3 inhibitors |
| 01/02/2007 | US7157420 Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| 01/02/2007 | US7157419 Growth factor binding molecules |
| 01/02/2007 | US7157418 Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders |
| 01/02/2007 | US7157279 Flowering genes |
| 01/02/2007 | US7157277 Factor VIII remodeling and glycoconjugation of Factor VIII |
| 01/02/2007 | US7157275 growing adherent cells using a cell adhesion promoting ("CAP") peptide covalently coupled to a cell adhesion resistant layer such as hyaluronic acid on a polystyrene surface to promote cell attachment, growth differentiation, in culture; biological scaffolds |
| 01/02/2007 | US7157273 Polypeptide, fusion protein; useful for producing an animal cell growth stimulating agent |
| 01/02/2007 | US7157267 Nucleic acid sequences for polypeptides that inhibit endothelial cell growth; PRO Polypeptides; homology to Fibroblast Growth Factor-8 (FGF-8) |
| 01/02/2007 | US7157266 Structure of adenovirus bound to cellular receptor car |
| 01/02/2007 | US7157259 Murine lecithin-cholesterol acyltransferase protein |
| 01/02/2007 | US7157250 Glutamic acid receptor and utilization thereof |
| 01/02/2007 | US7157249 Genetically engineered cell for use in human therapeutics and diagnostics |
| 01/02/2007 | US7157248 Anticonvulsants; anxiolytic agents; multiple sclerosis; isolated nucleic acids; analyzing sample; calibration |
| 01/02/2007 | US7157247 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/02/2007 | US7157246 RNA polymerase I transcription factor TIF-IA |
| 01/02/2007 | US7157245 Neisserial vaccine compositions and methods |
| 01/02/2007 | US7157244 Adenosine receptor |
| 01/02/2007 | US7157243 DNA encoding mammalian T-type calcium channels |
| 01/02/2007 | US7157235 Involving the detection of an elevated amount of Macrophage Inhibitory Cytokine-1 (MIC-1) in a test body sample |
| 01/02/2007 | US7157231 Method of evaluating useful cattle |
| 01/02/2007 | US7157226 probes, vectors and kits; sequences from the Core/E1 region of HCV type 3; detection of HCV infection |
| 01/02/2007 | US7157225 Nucleotide sequences of HIV-1 type (or subtype) O retrovirus antigens |
| 01/02/2007 | US7157091 Endosomal targeting signal contains an endosomal targeting portion of human invariant chain Ii or LAMP-1. |
| 01/02/2007 | US7157089 A fusion protein containing an antigen of an influenza virus and a bacterial stress protein; vaccines induce a cytolytic T-cell (CTL) response in a mammal |
| 01/02/2007 | US7157088 Surface protein of Leptospira |
| 01/02/2007 | US7157086 Treatment of specific and non-specific inflammation, including asthma; useful in diagnosing and localizing sites of inflammation. |
| 01/02/2007 | US7157079 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms |
| 01/02/2007 | US7156835 Method of applying composition to a surface |
| 01/02/2007 | CA2340795C Placental organic anion transporter and gene thereof |
| 01/02/2007 | CA2295219C Integrin binding peptide and use thereof |
| 01/02/2007 | CA2237207C Connector used for flexible flat cable |
| 01/02/2007 | CA2237059C Targeted adenovirus vectors |
| 01/02/2007 | CA2236900C Igg separation medium and novel protein a variant |
| 01/02/2007 | CA2197869C Therapeutic agent for cartilaginous diseases |
| 01/02/2007 | CA2174517C Receptor specific atrial natriuretic peptides |
| 12/29/2006 | CA2551345A1 Process for separating fibrinogen proteins, factor xiii and biological glue from a soluble plasma fraction and for preparing lyophilized concentrates of the said proteins |
| 12/29/2006 | CA2549477A1 Competitive regulation of hepcidin mrna by soluble and cell-associated hemojuvelin |
| 12/28/2006 | WO2006138721A1 Anti-gfralpha3 antibodies |
| 12/28/2006 | WO2006138668A2 Methods for treating dermatitis using mutant human il-4 compositions |
| 12/28/2006 | WO2006138567A2 Methods and compositions to elicit multivalent immune responses against dominant and subdominant epitopes, expressed on cancer cells and tumor stroma |
| 12/28/2006 | WO2006138527A2 Genes of an otitis media isolate of nontypeable haemophilus influenzae |
| 12/28/2006 | WO2006138520A2 Methods for isolating and concentrating biological materials using continuous-flow ultracentrifugation |
| 12/28/2006 | WO2006138509A2 Immunoreactive protein orthologs of ehrlichia canis and e. chaffeensis |
| 12/28/2006 | WO2006138219A2 Methods of diagnosis / prognosis of inflammatory conditions |
| 12/28/2006 | WO2006138160A2 Amyloid beta protein channel structure and uses thereof indentifying potential drug molecules for neurodegenerative diseases |
| 12/28/2006 | WO2006138038A1 Intralesional treatment of psoriasis |
| 12/28/2006 | WO2006138012A1 P450 substrates and methods related thereto |
| 12/28/2006 | WO2006138004A2 Immunogenic compositions for chlamydia trachomatis |
| 12/28/2006 | WO2006137598A1 Agent that modulates physiological condition of pests, involved in insect c-jun amino-terminal kinase activity |
| 12/28/2006 | WO2006137597A1 Novel physiological substance nesfatin, substance relevant thereto, and use of the substances |
| 12/28/2006 | WO2006137515A1 Therapeutic agent for cancer comprising polypeptide capable of inhibiting the function of synoviolin as active ingredient |
| 12/28/2006 | WO2006137075A1 Compositions and methods for preventing or treating hiv infection |
| 12/28/2006 | WO2006136906A2 Switch-peptides as tool for the study of fibrillogenesis |
| 12/28/2006 | WO2006136831A2 Gene expression technique |
| 12/28/2006 | WO2006136763A1 Synthetic ligands of peptide-mhc complexes, or cd1-antigen complexes |
| 12/28/2006 | WO2006136697A2 Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infection |
| 12/28/2006 | WO2006136392A2 Novel genes and proteins of brachyspira pilosicoli and use of same for diagnosis and therapy |
| 12/28/2006 | WO2006136162A2 Tuberculosis vaccines comprising antigens expressed during the latent infection phase |
| 12/28/2006 | WO2006136084A1 Fusion proteins of recombinant sars coronavirus structural proteins, their production and uses |
| 12/28/2006 | WO2006135985A1 Therapeutic pro-apoptotic bh3-like molecules and methods for generating and/or selecting the same |
| 12/28/2006 | WO2006120030A8 Erythropoietin variants |
| 12/28/2006 | WO2006119107A3 Sclerostin binding agents |
| 12/28/2006 | WO2006115633A3 Cyanine-chlorotoxin conjugate and method for intra-operative fluorescent visualization of cancer |
| 12/28/2006 | WO2006113559A3 Methods for modulating bone formation and mineralization by modulating krc activity |
| 12/28/2006 | WO2006112962A3 Syphilis diagnostic test and kits |
| 12/28/2006 | WO2006099480A3 Stress proteins and peptides and methods of use thereof |
| 12/28/2006 | WO2006097536A3 Dimeric peptide agonists of the glp-1 receptor |
| 12/28/2006 | WO2006089251A3 SYNERGISTIC EFFECT OF TGF-β BLOCKADE AND IMMUNOGENIC AGENTS ON TUMORS |
| 12/28/2006 | WO2006083275A3 Variable lymphocyte receptors, related polypeptides and nucleic acids, and uses thereof |
| 12/28/2006 | WO2006082253A3 Method for coating surfaces with hydrophobins |
| 12/28/2006 | WO2006082251A3 Novel hydrophobin fusion products, production and use thereof |
| 12/28/2006 | WO2006072625A3 Anti-kir combination treatments and methods |
| 12/28/2006 | WO2006070024A3 E1-minus adenoviruses and use thereof |
| 12/28/2006 | WO2006063075A3 Hemipteran octopamine receptor |
| 12/28/2006 | WO2006013462A3 Growth factors nsg28, nsg30, and nsg32 |
| 12/28/2006 | WO2005098433A3 Diagnostic assays for alzheimer’s disease |
| 12/28/2006 | WO2005089409A3 Sensor constructs and detection methods |
| 12/28/2006 | WO2005072049A3 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of endometriosis |
| 12/28/2006 | WO2004072239A3 Novel polypeptides with antifungal activity |
| 12/28/2006 | WO2004041067A3 Prevention and treatment of synucleinopathic disease |
| 12/28/2006 | WO2004038372A3 Cdkl1 as modifier of branching morphogenesis and methods of use |
| 12/28/2006 | WO2004020599A3 Hedgehog antagonists, methods and uses related thereto |
| 12/28/2006 | WO2003072714A3 Follistatin domain containing proteins |
| 12/28/2006 | US20060294623 Eukaryotic initiation factor 5A (eIF-5A) for use as tool in identifying modulators which prevent browning in plants; controlling aging in plants; enzyme inhibitors; storage stability; enhanced shelf life; deoxyhypusine synthase (DHS) |
| 12/28/2006 | US20060294622 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics |
| 12/28/2006 | US20060294621 Methods and compositions to modulate ethylene sensitivity |
| 12/28/2006 | US20060294618 imparting virus resistance to plants by silencing a gene encoding a translation initiation factor eIF4E or by overexpressing in a plant a nucleic acid molecule encoding a heterologous eIF4E |
| 12/28/2006 | US20060294617 Zinc finger proteins for DNA binding and gene regulation in plants |
| 12/28/2006 | US20060294615 Therapeutic and diagnostic applications of prostatic acid phosphatase in prostate cancer |